HomeALLO • NASDAQ
add
Allogene Therapeutics Inc
Previous close
$1.45
Day range
$1.38 - $1.49
Year range
$1.23 - $3.88
Market cap
310.69M USD
Avg Volume
3.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 15.52M | -9.90% |
Net income | -59.94M | 30.12% |
Net profit margin | — | — |
Earnings per share | -0.28 | 45.10% |
EBITDA | -57.26M | 16.28% |
Effective tax rate | -0.74% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 292.48M | -34.82% |
Total assets | 548.71M | -14.64% |
Total liabilities | 126.53M | -3.12% |
Total equity | 422.18M | — |
Shares outstanding | 217.26M | — |
Price to book | 0.73 | — |
Return on assets | -26.58% | — |
Return on capital | -28.29% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -59.94M | 30.12% |
Cash from operations | -36.70M | 31.67% |
Cash from investing | 54.93M | -18.57% |
Cash from financing | 5.74M | 3,605.16% |
Net change in cash | 23.98M | 72.40% |
Free cash flow | -17.23M | 41.79% |
About
Founded
2017
Headquarters
Website
Employees
226
